Disparities in cancer treatment among patients infected with the human immunodeficiency virus

Abstract

Human immunodeficiency virus (HIV)‐infected patients with cancer in the United States are less likely to receive cancer treatment compared with their uninfected counterparts, even after factoring in differences in insurance status and medical comorbidities. This disparity needs to be addressed as survival from HIV continues to improve and cancer becomes one of the leading causes of death in the HIV population.